Koninklijke Philips
Market Cap
€40.0b
Last Updated
2020/08/15 03:59 UTC
Data Sources
Company Financials +
Executive Summary
Koninklijke Philips N.V. operates as a health technology company worldwide.
Rewards
Risk Analysis
Snowflake Analysis
Adequate balance sheet and fair value.
Similar Companies
Share Price & News
How has Koninklijke Philips's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PHIA has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-0.8%
PHIA
0.1%
NL Medical Equipment
1.5%
NL Market
1 Year Return
8.4%
PHIA
17.1%
NL Medical Equipment
-6.5%
NL Market
Return vs Industry: PHIA underperformed the Dutch Medical Equipment industry which returned 17.1% over the past year.
Return vs Market: PHIA exceeded the Dutch Market which returned -6.5% over the past year.
Shareholder returns
| PHIA | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.8% | 0.1% | 1.5% |
| 30 Day | 1.9% | 1.0% | -2.3% |
| 90 Day | 19.1% | 8.4% | 12.0% |
| 1 Year | 8.4%8.4% | 18.2%17.1% | -3.9%-6.5% |
| 3 Year | 49.0%42.4% | 67.3%59.5% | 6.5%-4.1% |
| 5 Year | 118.3%96.3% | 142.8%122.3% | 36.4%11.2% |
Price Volatility Vs. Market
How volatile is Koninklijke Philips's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Does Koninklijke Philips' (AMS:PHIA) CEO Salary Compare Well With Industry Peers?3 weeks ago | Simply Wall St
Koninklijke Philips N.V. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next3 weeks ago | Simply Wall St
How Much Are Koninklijke Philips N.V. (AMS:PHIA) Insiders Taking Off The Table?Valuation
Is Koninklijke Philips undervalued compared to its fair value and its price relative to the market?
3.4%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PHIA (€44.25) is trading below our estimate of fair value (€45.79)
Significantly Below Fair Value: PHIA is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: PHIA is good value based on its PE Ratio (39.9x) compared to the XE Medical Equipment industry average (40.6x).
PE vs Market: PHIA is poor value based on its PE Ratio (39.9x) compared to the Dutch market (21.3x).
Price to Earnings Growth Ratio
PEG Ratio: PHIA is poor value based on its PEG Ratio (2.7x)
Price to Book Ratio
PB vs Industry: PHIA is good value based on its PB Ratio (3.7x) compared to the XE Medical Equipment industry average (4.3x).
Next Steps
Future Growth
How is Koninklijke Philips forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?
14.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHIA's forecast earnings growth (14.6% per year) is above the savings rate (0.4%).
Earnings vs Market: PHIA's earnings (14.6% per year) are forecast to grow slower than the Dutch market (26.2% per year).
High Growth Earnings: PHIA's earnings are forecast to grow, but not significantly.
Revenue vs Market: PHIA's revenue (5.4% per year) is forecast to grow slower than the Dutch market (7.5% per year).
High Growth Revenue: PHIA's revenue (5.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PHIA's Return on Equity is forecast to be low in 3 years time (13.8%).
Next Steps
Past Performance
How has Koninklijke Philips performed over the past 5 years?
26.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PHIA has a large one-off loss of €451.0M impacting its June 30 2020 financial results.
Growing Profit Margin: PHIA's current net profit margins (5.3%) are lower than last year (7.8%).
Past Earnings Growth Analysis
Earnings Trend: PHIA's earnings have grown significantly by 26% per year over the past 5 years.
Accelerating Growth: PHIA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PHIA had negative earnings growth (-30.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-10.1%).
Return on Equity
High ROE: PHIA's Return on Equity (9.3%) is considered low.
Next Steps
Financial Health
How is Koninklijke Philips's financial position?
Financial Position Analysis
Short Term Liabilities: PHIA's short term assets (€10.0B) exceed its short term liabilities (€7.5B).
Long Term Liabilities: PHIA's short term assets (€10.0B) exceed its long term liabilities (€9.0B).
Debt to Equity History and Analysis
Debt Level: PHIA's debt to equity ratio (51.8%) is considered high.
Reducing Debt: PHIA's debt to equity ratio has increased from 47.6% to 51.8% over the past 5 years.
Debt Coverage: PHIA's debt is well covered by operating cash flow (40.7%).
Interest Coverage: PHIA's interest payments on its debt are well covered by EBIT (27.7x coverage).
Balance Sheet
Next Steps
Dividend
What is Koninklijke Philips's current dividend yield, its reliability and sustainability?
2.26%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PHIA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PHIA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PHIA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PHIA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: PHIA is not paying a notable dividend for the Dutch market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of PHIA's dividend in 3 years as they are not forecast to pay a notable one for the Dutch market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.3yrs
Average management tenure
CEO
Frans van Houten (60 yo)
9.33yrs
Tenure
€5,260,111
Compensation
Mr. François Adrianus van Houten, also known as Frans, has been the Chief Executive Officer and Chairman of Management Board of Royal Philips at Philips India Limited since April 2011. Mr. van Houten serve ...
CEO Compensation Analysis
Compensation vs Market: Frans's total compensation ($USD6.22M) is about average for companies of similar size in the Dutch market ($USD5.15M).
Compensation vs Earnings: Frans's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board of Management & CEO | 9.33yrs | €5.26m | 0.047% € 18.8m | |
| Independent Vice-Chairwoman of the Supervisory Board & Secretary | no data | €187.17k | no data | |
| Executive VP | 4.83yrs | €2.60m | 0.014% € 5.4m | |
| Executive VP | 2.75yrs | €1.86m | 0.0098% € 3.9m | |
| EVP of Strategic Business Development & Member of Executive Committee | no data | no data | no data | |
| Executive VP & Chief of Operations | 3.92yrs | no data | no data | |
| Chief Business Leader of the Precision Diagnosis Businesses & Member of Executive Committee | 0.25yr | no data | no data | |
| Head of Investor Relations | 1yr | no data | no data | |
| Executive VP & Chief Human Resources Officer | 0.67yr | no data | no data | |
| Chief Design Officer | 8.75yrs | no data | no data | |
| Executive VP & Chief Business Leader of Connected Care Business | 1.83yrs | no data | no data | |
| Executive VP and Chief Innovation & Strategy Officer | 4.08yrs | no data | no data |
3.3yrs
Average Tenure
60yo
Average Age
Experienced Management: PHIA's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Vice-Chairwoman of the Supervisory Board & Secretary | no data | €187.17k | no data | |
| Independent Member of Supervisory Board | 6.25yrs | €131.83k | no data | |
| Independent Member of Supervisory Board | 5.25yrs | €158.50k | no data | |
| Independent Chairman of the Supervisory Board | 9.42yrs | €197.00k | 0.0021% € 828.0k | |
| Vice Chairman of Supervisory Board | 0.58yr | no data | no data | |
| Independent Member of Supervisory Board | 2yrs | €114.50k | no data | |
| Member of Supervisory Board | 0.33yr | no data | no data | |
| Independent Member of Supervisory Board | 8.33yrs | €145.00k | no data | |
| Independent Member of Supervisory Board | 1.83yrs | €121.33k | no data | |
| Independent Member of Supervisory Board | 1.25yrs | €51.50k | no data |
2.0yrs
Average Tenure
63yo
Average Age
Experienced Board: PHIA's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Koninklijke Philips N.V.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Koninklijke Philips N.V.
- Ticker: PHIA
- Exchange: ENXTAM
- Founded: 1891
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: €40.001b
- Shares outstanding: 903.97m
- Website: https://www.philips.com
Number of Employees
Location
- Koninklijke Philips N.V.
- Philips Center
- Amstelplein 2
- Amsterdam
- Noord-Holland
- 1096 BC
- Netherlands
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| PHG | NYSE (New York Stock Exchange) | ADR EACH REP 1 ORD EUR0.20 | US | USD | Jan 1980 | |
| PHIA | DB (Deutsche Boerse AG) | ADR EACH REP 1 ORD EUR0.20 | DE | EUR | Jan 1980 | |
| PHIA | XTRA (XETRA Trading Platform) | ADR EACH REP 1 ORD EUR0.20 | DE | EUR | Jan 1980 | |
| 0A2M | LSE (London Stock Exchange) | ADR EACH REP 1 ORD EUR0.20 | GB | USD | Jan 1980 | |
| RYLP.F | OTCPK (Pink Sheets LLC) | Yes | Common Shares | US | USD | Dec 1980 |
| PHI1 | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Dec 1980 |
| PHI | SWX (SIX Swiss Exchange) | Yes | Common Shares | CH | CHF | Dec 1980 |
| PHIA | ENXTAM (Euronext Amsterdam) | Yes | Common Shares | NL | EUR | Dec 1980 |
| PHIA | BIT (Borsa Italiana) | Yes | Common Shares | IT | EUR | Dec 1980 |
| PHI1 | XTRA (XETRA Trading Platform) | Yes | Common Shares | DE | EUR | Dec 1980 |
| 0LNG | LSE (London Stock Exchange) | Yes | Common Shares | GB | EUR | Dec 1980 |
| PHIAA | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Common Shares | GB | EUR | Dec 1980 |
| PHIA | WBAG (Wiener Boerse AG) | Yes | Common Shares | AT | EUR | Dec 1980 |
| PHIA N | BMV (Bolsa Mexicana de Valores) | Yes | Common Shares | MX | MXN | Dec 1980 |
Biography
Koninklijke Philips N.V. operates as a health technology company worldwide. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/08/15 03:59 |
| End of Day Share Price | 2020/08/14 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.